Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 126 results for "zidovudine"

Human medicines European public assessment report (EPAR): Tr...

This is a summary of the European public assessment report (EPAR) for Trizivir. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ... European Medicines Agency, 2 weeks ago

1 images for "zidovudine"

Drug Discovery and Development, 2 weeks ago

Mylan launches generic HIV-1 drug

Mylan Inc., a generic pharmaceutical company, has launched Lamivudine and Zidovudine Tablets USP, 150mg/300mg for the treatment of HIV-1 infection. Lamivudine and Zidovudine Tablets USP, 150mg/300mg are the generic version of Viiv's Combivir. ...
 Individual.com2 weeks ago Mylan unveils generic Combivir in the US, strengthening its growing antiretroviral franchise in the nation  Individual.com2 weeks ago Mylan debuts generic of ViiV's Combivir in USA  Pharma Letter2 weeks ago Mylan Inc. Launches Generic Combivir??  BioSpace2 weeks ago
[x]  

Foetal Loss and Enhanced Fertility Observed in Mice Treated with Zidovudine or Nevirapine

by Chika K. Onwuamah, Oliver C. Ezechi, Ebiere C. Herbertson, Rosemary A. Audu, Innocent A. O. Ujah, Peter G. C. Odeigah Background Health concerns for HIV-infected persons on antiretroviral therapy (ART) have moved from morbidity to the ...
 Plosone.org1 month ago

New and Generic Drug Approvals: Lamivudine; Zidovudine; Efavirenz

LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ LAMIVUDINE;ZIDOVUDINE;EFAVIRENZ 150MG; 300MG; 600MG TABLET;ORAL None (Tentative Approval) No
 U.S. Food and Drug Administration1 month ago New and Generic Drug Approvals: Atazanavir Sulfate;Ritonavir;Lamivudine;Zidovudine  U.S. Food and Drug Administration1 month ago

Tolerability, adherence and completion of new occupational post-exposure prophylaxis regimen (tenofovir + emtricitabine and raltegravir)

ID Week Oct 8-12 2014 Philadelphia Reported by Jules Levin IDSA Oct 8-12 2014 Philadelphia, PA Bock I1,2, Felsen U1,2, Catalano M1,2, Hacker S1, Zingman BS1,2 Montefiore Medical Center, Bronx, NY1; Albert Einstein College of Medicine, Bronx, ...
 National AIDS Treatment Advocacy Project1 day ago

HIV Antiretrovirals in Pregnancy: Which Are Safe?

Question What should be considered when selecting an HIV antiretroviral treatment regimen for a pregnant patient? Response from Elise Gilbert, PharmD Clinical Pharmacist, Northwestern Memorial Hospital, Chicago, Illinois For pregnant ...
 Medscape1 day ago Noninduced HIV-1 Proviruses in the Latent Reservoir May Contain Drug Resistance Mutations ......full slide presentation included  National AIDS Treatment Advocacy Project1 month ago HIV in Resting CD4 Cells May Contain Antiretroviral Resistance Mutations  National AIDS Treatment Advocacy Project1 month ago
Securities Technology Monitor

Earnings Releases, Conference Call Schedule, Acquisitions, Drug Launches, and Initiation of Study - Research Reports on KeyCorp, Itau Unibanco, BD, Mylan and GlaxoSmithKline

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, October 20, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding KeyCorp. (NYSE: KEY), Itau Unibanco Holding S.A. (NYSE: ...
 Scottrade3 days ago GLAXOSMITHKLINE : Earnings Releases, Conference Call Schedule, Acquisitions, Drug Launches, and Initiation of Study - Research Reports on KeyCorp, Itau Unibanco, BD, Mylan and GlaxoSmithKline  4 Traders3 days ago
[x]  

We are neglected, women living with HIV cry out

By Gabriel Olawale They wore long faces, their cries and lamentations loud and clear. With a common voice, they stated their case, telling stories of woe and anguish. As Persons Living With HIV/AIDS, PLWHA, they share a common destiny but with a ...
 Vanguard5 days ago

Three Quarters of NPEP Users Show Interest in Trying PrEP

ID Week Oct 8-12 2014 Philadelphia IDWeek 2014, October 8-12, 2014, Philadelphia Mark Mascolini Three quarters of men taking nonoccupational postexposure prophylaxis (NPEP) against HIV in a Boston study expressed interest in preexposure ...
 National AIDS Treatment Advocacy Project1 week ago

Experimental drugs against Ebola : Challenges and prospects

• Bitter kola seeds, kolaviron, GB-1 as possible post-exposure agents in management EBOLA virus infection of humans is a lethal and accidental dead-end event. There is no approved drug or vaccine currently available for the prevention or ...
 The Guardian Nigeria1 week ago Ebola Virus Patented by US Government in October 2009: Invention Related to Novel Species of Human Ebola (hEbola) virus  Global Research1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less